Skip to main content
OpenTrials
Completed

NCT Number: NCT05070507

Effect of an Enzyme-containing Lozenge on Dental Biofilm in Healthy Individuals.

The purpose of the study is to assess the effect of an enzyme containing lozenge on dental plaque accumulation in healthy adults.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Aarhus University

Aarhus C, 8000, Denmark

About this study

The purpose of this study is to examine the clinical effects of a lozenge containing enzymes on dental plaque accumulation and oral microbiome composition after professional dental cleaning, as compared to a placebo lozenge without enzymes. Furthermore, safety of the enzyme lozenge will be assessed by clinical evaluation of the oral hard and soft tissues. The null hypothesis is that the treatment with enzyme-containing lozenges do not affect plaque accumulation, as compared to a placebo control.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Generally healthy males and females ≥18 years of age.
  • Able to read, sign and receive a copy of the signed informed consent form.
  • Have at least 20 natural teeth.

Exclusion criteria

  • Clinically visible active caries lesions and/or periodontitis.
  • Significant oral soft tissue pathology based on a visual examination.
  • History of allergy or significant adverse events following use of oral hygiene products such as toothpastes, mouth rinses, breath mints, lozenges, or chewing gum or their ingredients.
  • History of allergies to ingredients in the test product.
  • History of allergies towards enzymes.
  • Self-reported as pregnant or nursing.
  • Self-reported serious medical conditions.
  • Antibiotic or anti-inflammatory medication within 30 days of screening visit.
  • Orthodontic appliances, including retainers, peri/oral piercings, or removable partial dentures.
  • Acute sinusitis or severe oral-pharyngeal infections.

Treatment and study plan

Enzyme containing lozenge

Dietary Supplement

Subjects are instructed to take one lozenge three times daily, at least 30 minutes after a meal, for seven days. No oral health care procedures are allowed during the intervention period.

Placebo lozenge

Dietary Supplement

Subjects are instructed to take one lozenge three times daily, at least 30 minutes after a meal, for seven days. No oral health care procedures are allowed during the intervention period.

Primary outcomes

  1. Accumulation of dental plaque after 24 hours

    Time frame: Change in dental plaque score from baseline to 24 hours' follow-up

    Dental plaque assessed by the modified Quigley-Hein Plaque Index

Secondary outcomes

  1. Accumulation of dental plaque after 7 days

    Time frame: Change in dental plaque score from baseline to 7 days' follow-up

    Dental plaque assessed by the modified Quigley-Hein Plaque Index

  2. Development of gingivitis after 7 days

    Time frame: Change in gingivitis score from baseline to 7 days' follow-up

    Gingivitis assessed by the Silness-Löe Plaque Index

  3. Microbial characterization of the oral microbiome from plaque and saliva samples

    Time frame: 7 days' follow-up

    Assessed by 16S rRNA sequencing

Sponsors and collaborators

Lead sponsor

Novozymes A/S

Industry

Collaborators

  • University of Aarhus

Registry information

Official study title

Preventive Effect of an Enzyme-containing Lozenge on Dental Biofilm Accumulation in Healthy Individuals: A Clinical Pilot Study.

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Oct 7, 2021
Registry last updated
Oct 7, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.